VBM Medizintechnik GmbH – FDA Warning Letter, Jun 10, 2010
On June 7-10, 2010, an FDA inspection of VBM Medizintechnik GmbH in Sulz Am Neckar, Germany, revealed that their QuickTrach Sterile Tracheostomy devices, Jet Ventilation Catheters (JVC), and Control Inflator Devices were adulterated under 21 U.S.C. 351(h) due to non-conformity with Quality System (QS) regulation (21 CFR Part 820).
Key violations included: 1. **Design Control Deficiencies (21 CFR 820.30):** Failure to document design validation (820.30(g)) and verification (820.30(f)) results in the design history file for the QuickTrach II. Inadequate procedures for design change validation/verification (820.30(i)), exemplified by an unvalidated talcum coating change for Control Monitors. Also, design review procedures lacked requirements for independent review (820.30(e)). 2. **Corrective and Preventive Action (CAPA) Issues (21 CFR 820.100):** Failure to verify/validate CAPA effectiveness (820.100(a)(4)) and adequately document CAPA activities/results (820.100(b)). 3. **Complaint Handling (2
- Company
- VBM Medizintechnik GmbH
- Inspection date
- June 10, 2010
- Product type
- Devices
ID · d0d8a9f8-4cf8-48bd-abc5-3a20f505d179
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.